Friday, July 17, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reaffirms Positive Outlook on Cohen Steers with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
Finance_Capitalization
0
SHARES
19
VIEWS
Share on FacebookShare on Twitter

On March 8, 2024, analyst John Dunn from Evercore ISI Group reaffirmed his positive outlook on Cohen & Steers (NYSE:CNS), giving it an Outperform rating. He also increased the price target for the stock from $77 to $78. Looking ahead, the average stock forecast for Cohen & Steers Inc (CNS) over the next year is $75.48 USD, suggesting a potential upside of 7.83%.

CNS Stock Shows Strong Performance on March 8, 2024: Positive Sign for Investors

On March 8, 2024, CNS stock had a strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. According to data from CNN Money, the price of CNS shares increased by $0.99 since the market last closed, representing a 1.31% rise.

The stock opened at $76.27, which was $0.51 higher than its previous close. This positive price momentum indicates that investors have confidence in the company and its future prospects.

CNS’s strong performance on March 8th may be attributed to a variety of factors, such as positive earnings reports, new product launches, or overall market trends. Investors may be optimistic about the company’s growth potential and are willing to buy shares at a higher price.

It is important to note that stock prices can be volatile and subject to market fluctuations. While CNS had a positive trading day on March 8th, there is no guarantee that this momentum will continue in the future.

Investors should conduct thorough research and consider their own risk tolerance before making investment decisions. Consulting with a financial advisor can also provide valuable insights and guidance on navigating the stock market.

Overall, CNS’s strong performance on March 8, 2024, is a positive sign for the company and its shareholders. With continued momentum and favorable market conditions, CNS may continue to see growth and success in the future.

CNS Stock Performance Declines in 2024: Revenue and Net Income Drop, EPS Decreases

On March 8, 2024, CNS stock performance was closely watched by investors as the company released its financial results for the past year and the fourth quarter. According to data from CNN Money, CNS reported a total revenue of $483.62 million for the past year, which was a decrease of 15.75% compared to the previous year. The total revenue for the fourth quarter was $116.86 million, which remained flat compared to the previous quarter.

In terms of net income, CNS reported a net income of $129.05 million for the past year, which was a decrease of 24.55% compared to the previous year. The net income for the fourth quarter was $29.82 million, which also remained flat compared to the previous quarter.

Earnings per share (EPS) for CNS were reported at $2.60 for the past year, which was a decrease of 24.94% compared to the previous year. The EPS for the fourth quarter was $0.60, which was a decrease of 7.44% compared to the previous quarter.

Overall, the financial results for CNS showed a decline in both total revenue and net income compared to the previous year. However, the company was able to maintain its revenue and income levels from the previous quarter. The decrease in EPS indicates that the company’s profitability has been impacted by various factors.

Investors and analysts will be closely monitoring CNS stock performance in the coming days to see how the market reacts to these financial results. It will be interesting to see how CNS plans to address the challenges it is facing and whether it can turn its performance around in the future.

Tags: CNS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Chart up

Analyst Reaffirms Positive Outlook on Duckhorn Portfolio with Adjusted Price Target

Finance_ Chart Down

Analyst Reaffirms Positive Outlook on Federated Hermes with Increased Price Target

Real Estate Investment Trading online

Safe and Green Development Corp Expands Norman Berry Property for Senior Living Facility

Recommended

Unitedhealth Stock

Could Warren Buffett’s Investment Signal a Turnaround for UnitedHealth?

11 months ago
Amazon Stock

Amazon’s AI Ambitions Offset by Logistics Headwinds

4 months ago
Commerzbank Stock

Commerzbank’s Standalone Strategy Intensifies as BaFin Clamps Down on UniCredit

3 months ago
TKMS Stock

TKMS: A Naval Giant’s Fate Hinges on Three Critical Weeks

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

AppLovin’s Insider Exodus and Pixel Slowdown Raise Questions Ahead of Earnings

Pentixapharm’s Busy Week: FDA Fast-Track, Rights Offering, and a BaFin Review All in Play

Lang & Schwarz Trades Below Book Value as It Unveils €30m Structured Products Profit and €2 Dividend

Behind Micron’s 25% Rout: A Fully Booked HBM Pipeline and $25 Billion in New Factories

SanDisk’s Plunge Meets a Wall of Institutional Buying as Analysts Split on AI Demand

From Cost Center to Cloud: Meta’s Infrastructure Avalanche Meets a Skeptical Analyst

Trending

ABB Stock
European Markets

Record Orders and a Pricy Takeover: ABB Stakes Its Future on Rotork and a Robotics Exit

by Rodolfo Hanigan
July 17, 2026
0

ABB is in the midst of a sweeping portfolio overhaul that few investors expected to come at...

Allianz Stock

Allianz Defies Jefferies’ Stubborn €325 Target as Buyback Hits €1.5B and Bullish Calls Multiply

July 17, 2026
Caterpillar Stock

Caterpillar’s Two-Speed Engine: Record Backlog Masks Cyclical Headwinds

July 17, 2026
Applovin Stock

AppLovin’s Insider Exodus and Pixel Slowdown Raise Questions Ahead of Earnings

July 17, 2026
Pentixapharm Stock

Pentixapharm’s Busy Week: FDA Fast-Track, Rights Offering, and a BaFin Review All in Play

July 17, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Record Orders and a Pricy Takeover: ABB Stakes Its Future on Rotork and a Robotics Exit
  • Allianz Defies Jefferies’ Stubborn €325 Target as Buyback Hits €1.5B and Bullish Calls Multiply
  • Caterpillar’s Two-Speed Engine: Record Backlog Masks Cyclical Headwinds

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com